Results 181 to 190 of about 12,335 (206)

B7-H3 in glioblastoma and beyond: significance and therapeutic strategies. [PDF]

Front Immunol
Babič D, Jovčevska I, Zottel A.
europepmc   +1 more source

Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy. [PDF]

NPJ Vaccines
Ke TW, Chen CY, Chen WT, Tsai YY, Chiang SF, Huang CH, Lin YS, Chen TH, Chen TW, Liang JA, Chao KSC, Huang KC.   +11 more
europepmc   +1 more source

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression. [PDF]

Clin Transl Med
Liu J, Bewicke-Copley H, Patel S, Emanuel O, Counsell N, Sharma SJ, Schartinger V, Siefer O, Wieland U, Würdemann N, Garcia-Marin R, Dudas J, Patel D, Allen D, Guppy N, Linares J, Resende-Alves A, Howard DJ, Masterson L, Vaz FM, O'Flynn P, Forde CT, Williams L, Rehman U, Hartley JA, Haybaeck J, Riechelmann H, Jay A, Fenton TR, Forster MD, Adegun O, Chester K, McDermott J, Sandison A, Rodriguez Justo M, Rodrigo JP, Hermsen M, Tadross JA, Klussmann JP, Lechner M.   +39 more
europepmc   +1 more source

155OCHEMOTHERAPY OF MALIGNANT PLEURAL MESOTHELIOMA DOES NOT PRECLUDE USE OF CHECK-POINT BLOCKADE [PDF]

, 2017
Cecconi, V., Curioni Fontecedro, A., Felley Bosco, E., Schmitt-Opitz, I., Stahel, R.A., Tischler, V., van den Broek, M., Weder, W.   +7 more
core  

Prognostic Biomarkers in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Focus on B7-H3. [PDF]

Brain Sci
Yüceer RO, Kaya S, Balcı SN, Eğilmez HR, Yılmaz M, Erdıs E.   +5 more
europepmc   +1 more source

HDAC inhibitor (SAHA) enhances B7-H3-specific CAR T cell cytotoxic efficacy against chondrosarcoma cells and prolongs survival in an orthotopic mouse model. [PDF]

Transl Oncol
Osei-Hwedieh DO, He L, Wang K, Fan S, Ferrone S, Wang X, Schwab JH.   +6 more
europepmc   +1 more source

From tumor immunity to precision medicine: the next step in B7-H3/CD276 research. [PDF]

Med Rev (2021)
Fang H, Liu Y, Wang G, Liu HJ.
europepmc   +1 more source

B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancer. [PDF]

J Immunother Cancer
Stucchi S, Borea R, Garcia-Recio S, Zingarelli M, Rädler PD, Camerini E, Marnata Pellegry C, O'Connor S, Earp HS, Carey LA, Perou CM, Savoldo B, Dotti G.   +12 more
europepmc   +1 more source

RETRACTION: Fibronectin Enhances Tumor Metastasis Through B7-H3 in Clear Cell Renal Cell Carcinoma. [PDF]

FEBS Open Bio
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Soluble B7-H3 in colorectal cancer

Bulletin of Experimental Biology and Medicine, 2023
We present the results of comparative ELISA of the concentration of soluble form of immunity checkpoint B7-H3 (sB7-H3) in the serum of patients with colorectal cancer (CRC) at different stages before treatment and healthy control donors. The analysis revealed a statistically significant difference between the median levels of sB7-H3 in the blood serum ...
O V, Kovaleva, A N, Gratchev, N Yu, Sokolov, V V, Maslennikov, Yu B, Kuzmin, E S, Gershtein, A A, Alferov, Z Z, Mamedli, I S, Stilidi, N E, Kushlinskii   +9 more
openaire   +2 more sources